Global Enzalutamide Drugs Market Growth 2026-2032
The global Enzalutamide Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Enzalutamide drugs are medications that contain enzalutamide, an androgen receptor inhibitor that works by blocking the effects of androgens (male hormones like testosterone) on cancer cells.
United States market for Enzalutamide Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Enzalutamide Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Enzalutamide Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Enzalutamide Drugs players cover Astellas Pharma, Pfizer, Intas Pharmaceuticals, Beacon pharma, Aprazer Healthcare Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Enzalutamide Drugs Industry Forecast? looks at past sales and reviews total world Enzalutamide Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Enzalutamide Drugs sales for 2026 through 2032. With Enzalutamide Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enzalutamide Drugs industry.
This Insight Report provides a comprehensive analysis of the global Enzalutamide Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enzalutamide Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Enzalutamide Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enzalutamide Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enzalutamide Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Enzalutamide Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Enzalutamide Drugs market?
What factors are driving Enzalutamide Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enzalutamide Drugs market opportunities vary by end market size?
How does Enzalutamide Drugs break out by Type, by Application?
Enzalutamide drugs are medications that contain enzalutamide, an androgen receptor inhibitor that works by blocking the effects of androgens (male hormones like testosterone) on cancer cells.
United States market for Enzalutamide Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Enzalutamide Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Enzalutamide Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Enzalutamide Drugs players cover Astellas Pharma, Pfizer, Intas Pharmaceuticals, Beacon pharma, Aprazer Healthcare Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Enzalutamide Drugs Industry Forecast? looks at past sales and reviews total world Enzalutamide Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Enzalutamide Drugs sales for 2026 through 2032. With Enzalutamide Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enzalutamide Drugs industry.
This Insight Report provides a comprehensive analysis of the global Enzalutamide Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enzalutamide Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Enzalutamide Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enzalutamide Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enzalutamide Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Enzalutamide Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Tablets
- Capsules
- Hospital and Clinic
- Retail Pharmacies
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Astellas Pharma
- Pfizer
- Intas Pharmaceuticals
- Beacon pharma
- Aprazer Healthcare Pharma
- Arechar Healthcare
- Glenmark Pharma
- Sun Pharma
- Zydus
- Abbott Laboratories
- BDR Pharma
- Qilu Pharmaceutical
- Kelun Pharmaceutical
- Yichang Humanwell Pharmaceutical
- Jiangsu Hansoh Pharmaceutical
- PuraCap Pharmaceuticals
- Shenyang Hongqi Pharmaceutical
What is the 10-year outlook for the global Enzalutamide Drugs market?
What factors are driving Enzalutamide Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enzalutamide Drugs market opportunities vary by end market size?
How does Enzalutamide Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Enzalutamide Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Enzalutamide Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Enzalutamide Drugs by Country/Region, 2021, 2025 & 2032
2.2 Enzalutamide Drugs Segment by Type
2.2.1 Tablets
2.2.2 Capsules
2.2.3 Enzalutamide Drugs Sales by Type
2.2.3.1 Global Enzalutamide Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global Enzalutamide Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Enzalutamide Drugs Sale Price by Type (2021-2026)
2.3 Enzalutamide Drugs Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Retail Pharmacies
2.3.3 Other
2.3.4 Enzalutamide Drugs Sales by Application
2.3.4.1 Global Enzalutamide Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global Enzalutamide Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Enzalutamide Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Enzalutamide Drugs Breakdown Data by Company
3.1.1 Global Enzalutamide Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Enzalutamide Drugs Sales Market Share by Company (2021-2026)
3.2 Global Enzalutamide Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Enzalutamide Drugs Revenue by Company (2021-2026)
3.2.2 Global Enzalutamide Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Enzalutamide Drugs Sale Price by Company
3.4 Key Manufacturers Enzalutamide Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Enzalutamide Drugs Product Location Distribution
3.4.2 Players Enzalutamide Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ENZALUTAMIDE DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Enzalutamide Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Enzalutamide Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Enzalutamide Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Enzalutamide Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Enzalutamide Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Enzalutamide Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Enzalutamide Drugs Sales Growth
4.4 APAC Enzalutamide Drugs Sales Growth
4.5 Europe Enzalutamide Drugs Sales Growth
4.6 Middle East & Africa Enzalutamide Drugs Sales Growth
5 AMERICAS
5.1 Americas Enzalutamide Drugs Sales by Country
5.1.1 Americas Enzalutamide Drugs Sales by Country (2021-2026)
5.1.2 Americas Enzalutamide Drugs Revenue by Country (2021-2026)
5.2 Americas Enzalutamide Drugs Sales by Type (2021-2026)
5.3 Americas Enzalutamide Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Enzalutamide Drugs Sales by Region
6.1.1 APAC Enzalutamide Drugs Sales by Region (2021-2026)
6.1.2 APAC Enzalutamide Drugs Revenue by Region (2021-2026)
6.2 APAC Enzalutamide Drugs Sales by Type (2021-2026)
6.3 APAC Enzalutamide Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Enzalutamide Drugs by Country
7.1.1 Europe Enzalutamide Drugs Sales by Country (2021-2026)
7.1.2 Europe Enzalutamide Drugs Revenue by Country (2021-2026)
7.2 Europe Enzalutamide Drugs Sales by Type (2021-2026)
7.3 Europe Enzalutamide Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Enzalutamide Drugs by Country
8.1.1 Middle East & Africa Enzalutamide Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Enzalutamide Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Enzalutamide Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Enzalutamide Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Enzalutamide Drugs
10.3 Manufacturing Process Analysis of Enzalutamide Drugs
10.4 Industry Chain Structure of Enzalutamide Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Enzalutamide Drugs Distributors
11.3 Enzalutamide Drugs Customer
12 WORLD FORECAST REVIEW FOR ENZALUTAMIDE DRUGS BY GEOGRAPHIC REGION
12.1 Global Enzalutamide Drugs Market Size Forecast by Region
12.1.1 Global Enzalutamide Drugs Forecast by Region (2027-2032)
12.1.2 Global Enzalutamide Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Enzalutamide Drugs Forecast by Type (2027-2032)
12.7 Global Enzalutamide Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Astellas Pharma
13.1.1 Astellas Pharma Company Information
13.1.2 Astellas Pharma Enzalutamide Drugs Product Portfolios and Specifications
13.1.3 Astellas Pharma Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Astellas Pharma Main Business Overview
13.1.5 Astellas Pharma Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Enzalutamide Drugs Product Portfolios and Specifications
13.2.3 Pfizer Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Intas Pharmaceuticals
13.3.1 Intas Pharmaceuticals Company Information
13.3.2 Intas Pharmaceuticals Enzalutamide Drugs Product Portfolios and Specifications
13.3.3 Intas Pharmaceuticals Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Intas Pharmaceuticals Main Business Overview
13.3.5 Intas Pharmaceuticals Latest Developments
13.4 Beacon pharma
13.4.1 Beacon pharma Company Information
13.4.2 Beacon pharma Enzalutamide Drugs Product Portfolios and Specifications
13.4.3 Beacon pharma Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Beacon pharma Main Business Overview
13.4.5 Beacon pharma Latest Developments
13.5 Aprazer Healthcare Pharma
13.5.1 Aprazer Healthcare Pharma Company Information
13.5.2 Aprazer Healthcare Pharma Enzalutamide Drugs Product Portfolios and Specifications
13.5.3 Aprazer Healthcare Pharma Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Aprazer Healthcare Pharma Main Business Overview
13.5.5 Aprazer Healthcare Pharma Latest Developments
13.6 Arechar Healthcare
13.6.1 Arechar Healthcare Company Information
13.6.2 Arechar Healthcare Enzalutamide Drugs Product Portfolios and Specifications
13.6.3 Arechar Healthcare Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Arechar Healthcare Main Business Overview
13.6.5 Arechar Healthcare Latest Developments
13.7 Glenmark Pharma
13.7.1 Glenmark Pharma Company Information
13.7.2 Glenmark Pharma Enzalutamide Drugs Product Portfolios and Specifications
13.7.3 Glenmark Pharma Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Glenmark Pharma Main Business Overview
13.7.5 Glenmark Pharma Latest Developments
13.8 Sun Pharma
13.8.1 Sun Pharma Company Information
13.8.2 Sun Pharma Enzalutamide Drugs Product Portfolios and Specifications
13.8.3 Sun Pharma Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sun Pharma Main Business Overview
13.8.5 Sun Pharma Latest Developments
13.9 Zydus
13.9.1 Zydus Company Information
13.9.2 Zydus Enzalutamide Drugs Product Portfolios and Specifications
13.9.3 Zydus Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Zydus Main Business Overview
13.9.5 Zydus Latest Developments
13.10 Abbott Laboratories
13.10.1 Abbott Laboratories Company Information
13.10.2 Abbott Laboratories Enzalutamide Drugs Product Portfolios and Specifications
13.10.3 Abbott Laboratories Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Abbott Laboratories Main Business Overview
13.10.5 Abbott Laboratories Latest Developments
13.11 BDR Pharma
13.11.1 BDR Pharma Company Information
13.11.2 BDR Pharma Enzalutamide Drugs Product Portfolios and Specifications
13.11.3 BDR Pharma Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 BDR Pharma Main Business Overview
13.11.5 BDR Pharma Latest Developments
13.12 Qilu Pharmaceutical
13.12.1 Qilu Pharmaceutical Company Information
13.12.2 Qilu Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
13.12.3 Qilu Pharmaceutical Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Qilu Pharmaceutical Main Business Overview
13.12.5 Qilu Pharmaceutical Latest Developments
13.13 Kelun Pharmaceutical
13.13.1 Kelun Pharmaceutical Company Information
13.13.2 Kelun Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
13.13.3 Kelun Pharmaceutical Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Kelun Pharmaceutical Main Business Overview
13.13.5 Kelun Pharmaceutical Latest Developments
13.14 Yichang Humanwell Pharmaceutical
13.14.1 Yichang Humanwell Pharmaceutical Company Information
13.14.2 Yichang Humanwell Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
13.14.3 Yichang Humanwell Pharmaceutical Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Yichang Humanwell Pharmaceutical Main Business Overview
13.14.5 Yichang Humanwell Pharmaceutical Latest Developments
13.15 Jiangsu Hansoh Pharmaceutical
13.15.1 Jiangsu Hansoh Pharmaceutical Company Information
13.15.2 Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
13.15.3 Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Jiangsu Hansoh Pharmaceutical Main Business Overview
13.15.5 Jiangsu Hansoh Pharmaceutical Latest Developments
13.16 PuraCap Pharmaceuticals
13.16.1 PuraCap Pharmaceuticals Company Information
13.16.2 PuraCap Pharmaceuticals Enzalutamide Drugs Product Portfolios and Specifications
13.16.3 PuraCap Pharmaceuticals Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 PuraCap Pharmaceuticals Main Business Overview
13.16.5 PuraCap Pharmaceuticals Latest Developments
13.17 Shenyang Hongqi Pharmaceutical
13.17.1 Shenyang Hongqi Pharmaceutical Company Information
13.17.2 Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
13.17.3 Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Shenyang Hongqi Pharmaceutical Main Business Overview
13.17.5 Shenyang Hongqi Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Enzalutamide Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Enzalutamide Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Enzalutamide Drugs by Country/Region, 2021, 2025 & 2032
2.2 Enzalutamide Drugs Segment by Type
2.2.1 Tablets
2.2.2 Capsules
2.2.3 Enzalutamide Drugs Sales by Type
2.2.3.1 Global Enzalutamide Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global Enzalutamide Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Enzalutamide Drugs Sale Price by Type (2021-2026)
2.3 Enzalutamide Drugs Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Retail Pharmacies
2.3.3 Other
2.3.4 Enzalutamide Drugs Sales by Application
2.3.4.1 Global Enzalutamide Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global Enzalutamide Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Enzalutamide Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Enzalutamide Drugs Breakdown Data by Company
3.1.1 Global Enzalutamide Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Enzalutamide Drugs Sales Market Share by Company (2021-2026)
3.2 Global Enzalutamide Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Enzalutamide Drugs Revenue by Company (2021-2026)
3.2.2 Global Enzalutamide Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Enzalutamide Drugs Sale Price by Company
3.4 Key Manufacturers Enzalutamide Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Enzalutamide Drugs Product Location Distribution
3.4.2 Players Enzalutamide Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ENZALUTAMIDE DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Enzalutamide Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Enzalutamide Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Enzalutamide Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Enzalutamide Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Enzalutamide Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Enzalutamide Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Enzalutamide Drugs Sales Growth
4.4 APAC Enzalutamide Drugs Sales Growth
4.5 Europe Enzalutamide Drugs Sales Growth
4.6 Middle East & Africa Enzalutamide Drugs Sales Growth
5 AMERICAS
5.1 Americas Enzalutamide Drugs Sales by Country
5.1.1 Americas Enzalutamide Drugs Sales by Country (2021-2026)
5.1.2 Americas Enzalutamide Drugs Revenue by Country (2021-2026)
5.2 Americas Enzalutamide Drugs Sales by Type (2021-2026)
5.3 Americas Enzalutamide Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Enzalutamide Drugs Sales by Region
6.1.1 APAC Enzalutamide Drugs Sales by Region (2021-2026)
6.1.2 APAC Enzalutamide Drugs Revenue by Region (2021-2026)
6.2 APAC Enzalutamide Drugs Sales by Type (2021-2026)
6.3 APAC Enzalutamide Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Enzalutamide Drugs by Country
7.1.1 Europe Enzalutamide Drugs Sales by Country (2021-2026)
7.1.2 Europe Enzalutamide Drugs Revenue by Country (2021-2026)
7.2 Europe Enzalutamide Drugs Sales by Type (2021-2026)
7.3 Europe Enzalutamide Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Enzalutamide Drugs by Country
8.1.1 Middle East & Africa Enzalutamide Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Enzalutamide Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Enzalutamide Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Enzalutamide Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Enzalutamide Drugs
10.3 Manufacturing Process Analysis of Enzalutamide Drugs
10.4 Industry Chain Structure of Enzalutamide Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Enzalutamide Drugs Distributors
11.3 Enzalutamide Drugs Customer
12 WORLD FORECAST REVIEW FOR ENZALUTAMIDE DRUGS BY GEOGRAPHIC REGION
12.1 Global Enzalutamide Drugs Market Size Forecast by Region
12.1.1 Global Enzalutamide Drugs Forecast by Region (2027-2032)
12.1.2 Global Enzalutamide Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Enzalutamide Drugs Forecast by Type (2027-2032)
12.7 Global Enzalutamide Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Astellas Pharma
13.1.1 Astellas Pharma Company Information
13.1.2 Astellas Pharma Enzalutamide Drugs Product Portfolios and Specifications
13.1.3 Astellas Pharma Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Astellas Pharma Main Business Overview
13.1.5 Astellas Pharma Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Enzalutamide Drugs Product Portfolios and Specifications
13.2.3 Pfizer Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Intas Pharmaceuticals
13.3.1 Intas Pharmaceuticals Company Information
13.3.2 Intas Pharmaceuticals Enzalutamide Drugs Product Portfolios and Specifications
13.3.3 Intas Pharmaceuticals Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Intas Pharmaceuticals Main Business Overview
13.3.5 Intas Pharmaceuticals Latest Developments
13.4 Beacon pharma
13.4.1 Beacon pharma Company Information
13.4.2 Beacon pharma Enzalutamide Drugs Product Portfolios and Specifications
13.4.3 Beacon pharma Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Beacon pharma Main Business Overview
13.4.5 Beacon pharma Latest Developments
13.5 Aprazer Healthcare Pharma
13.5.1 Aprazer Healthcare Pharma Company Information
13.5.2 Aprazer Healthcare Pharma Enzalutamide Drugs Product Portfolios and Specifications
13.5.3 Aprazer Healthcare Pharma Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Aprazer Healthcare Pharma Main Business Overview
13.5.5 Aprazer Healthcare Pharma Latest Developments
13.6 Arechar Healthcare
13.6.1 Arechar Healthcare Company Information
13.6.2 Arechar Healthcare Enzalutamide Drugs Product Portfolios and Specifications
13.6.3 Arechar Healthcare Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Arechar Healthcare Main Business Overview
13.6.5 Arechar Healthcare Latest Developments
13.7 Glenmark Pharma
13.7.1 Glenmark Pharma Company Information
13.7.2 Glenmark Pharma Enzalutamide Drugs Product Portfolios and Specifications
13.7.3 Glenmark Pharma Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Glenmark Pharma Main Business Overview
13.7.5 Glenmark Pharma Latest Developments
13.8 Sun Pharma
13.8.1 Sun Pharma Company Information
13.8.2 Sun Pharma Enzalutamide Drugs Product Portfolios and Specifications
13.8.3 Sun Pharma Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sun Pharma Main Business Overview
13.8.5 Sun Pharma Latest Developments
13.9 Zydus
13.9.1 Zydus Company Information
13.9.2 Zydus Enzalutamide Drugs Product Portfolios and Specifications
13.9.3 Zydus Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Zydus Main Business Overview
13.9.5 Zydus Latest Developments
13.10 Abbott Laboratories
13.10.1 Abbott Laboratories Company Information
13.10.2 Abbott Laboratories Enzalutamide Drugs Product Portfolios and Specifications
13.10.3 Abbott Laboratories Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Abbott Laboratories Main Business Overview
13.10.5 Abbott Laboratories Latest Developments
13.11 BDR Pharma
13.11.1 BDR Pharma Company Information
13.11.2 BDR Pharma Enzalutamide Drugs Product Portfolios and Specifications
13.11.3 BDR Pharma Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 BDR Pharma Main Business Overview
13.11.5 BDR Pharma Latest Developments
13.12 Qilu Pharmaceutical
13.12.1 Qilu Pharmaceutical Company Information
13.12.2 Qilu Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
13.12.3 Qilu Pharmaceutical Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Qilu Pharmaceutical Main Business Overview
13.12.5 Qilu Pharmaceutical Latest Developments
13.13 Kelun Pharmaceutical
13.13.1 Kelun Pharmaceutical Company Information
13.13.2 Kelun Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
13.13.3 Kelun Pharmaceutical Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Kelun Pharmaceutical Main Business Overview
13.13.5 Kelun Pharmaceutical Latest Developments
13.14 Yichang Humanwell Pharmaceutical
13.14.1 Yichang Humanwell Pharmaceutical Company Information
13.14.2 Yichang Humanwell Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
13.14.3 Yichang Humanwell Pharmaceutical Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Yichang Humanwell Pharmaceutical Main Business Overview
13.14.5 Yichang Humanwell Pharmaceutical Latest Developments
13.15 Jiangsu Hansoh Pharmaceutical
13.15.1 Jiangsu Hansoh Pharmaceutical Company Information
13.15.2 Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
13.15.3 Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Jiangsu Hansoh Pharmaceutical Main Business Overview
13.15.5 Jiangsu Hansoh Pharmaceutical Latest Developments
13.16 PuraCap Pharmaceuticals
13.16.1 PuraCap Pharmaceuticals Company Information
13.16.2 PuraCap Pharmaceuticals Enzalutamide Drugs Product Portfolios and Specifications
13.16.3 PuraCap Pharmaceuticals Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 PuraCap Pharmaceuticals Main Business Overview
13.16.5 PuraCap Pharmaceuticals Latest Developments
13.17 Shenyang Hongqi Pharmaceutical
13.17.1 Shenyang Hongqi Pharmaceutical Company Information
13.17.2 Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
13.17.3 Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Shenyang Hongqi Pharmaceutical Main Business Overview
13.17.5 Shenyang Hongqi Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Enzalutamide Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Enzalutamide Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Capsules
Table 5. Global Enzalutamide Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Enzalutamide Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Enzalutamide Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Enzalutamide Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Enzalutamide Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Enzalutamide Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Enzalutamide Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Enzalutamide Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Enzalutamide Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Enzalutamide Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Enzalutamide Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Enzalutamide Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Enzalutamide Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Enzalutamide Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Enzalutamide Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Enzalutamide Drugs Producing Area Distribution and Sales Area
Table 21. Players Enzalutamide Drugs Products Offered
Table 22. Enzalutamide Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Enzalutamide Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Enzalutamide Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Enzalutamide Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Enzalutamide Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Enzalutamide Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Enzalutamide Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Enzalutamide Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Enzalutamide Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Enzalutamide Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Enzalutamide Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Enzalutamide Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Enzalutamide Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Enzalutamide Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Enzalutamide Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Enzalutamide Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Enzalutamide Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Enzalutamide Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Enzalutamide Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Enzalutamide Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Enzalutamide Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Enzalutamide Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Enzalutamide Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Enzalutamide Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Enzalutamide Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Enzalutamide Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Enzalutamide Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Enzalutamide Drugs
Table 52. Key Market Challenges & Risks of Enzalutamide Drugs
Table 53. Key Industry Trends of Enzalutamide Drugs
Table 54. Enzalutamide Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Enzalutamide Drugs Distributors List
Table 57. Enzalutamide Drugs Customer List
Table 58. Global Enzalutamide Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Enzalutamide Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Enzalutamide Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Enzalutamide Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Enzalutamide Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Enzalutamide Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Enzalutamide Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Enzalutamide Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Enzalutamide Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Enzalutamide Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Enzalutamide Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Enzalutamide Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Enzalutamide Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Enzalutamide Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Astellas Pharma Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Astellas Pharma Enzalutamide Drugs Product Portfolios and Specifications
Table 74. Astellas Pharma Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Astellas Pharma Main Business
Table 76. Astellas Pharma Latest Developments
Table 77. Pfizer Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer Enzalutamide Drugs Product Portfolios and Specifications
Table 79. Pfizer Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. Intas Pharmaceuticals Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Intas Pharmaceuticals Enzalutamide Drugs Product Portfolios and Specifications
Table 84. Intas Pharmaceuticals Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Intas Pharmaceuticals Main Business
Table 86. Intas Pharmaceuticals Latest Developments
Table 87. Beacon pharma Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Beacon pharma Enzalutamide Drugs Product Portfolios and Specifications
Table 89. Beacon pharma Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Beacon pharma Main Business
Table 91. Beacon pharma Latest Developments
Table 92. Aprazer Healthcare Pharma Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Aprazer Healthcare Pharma Enzalutamide Drugs Product Portfolios and Specifications
Table 94. Aprazer Healthcare Pharma Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Aprazer Healthcare Pharma Main Business
Table 96. Aprazer Healthcare Pharma Latest Developments
Table 97. Arechar Healthcare Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Arechar Healthcare Enzalutamide Drugs Product Portfolios and Specifications
Table 99. Arechar Healthcare Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Arechar Healthcare Main Business
Table 101. Arechar Healthcare Latest Developments
Table 102. Glenmark Pharma Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Glenmark Pharma Enzalutamide Drugs Product Portfolios and Specifications
Table 104. Glenmark Pharma Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Glenmark Pharma Main Business
Table 106. Glenmark Pharma Latest Developments
Table 107. Sun Pharma Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Sun Pharma Enzalutamide Drugs Product Portfolios and Specifications
Table 109. Sun Pharma Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Sun Pharma Main Business
Table 111. Sun Pharma Latest Developments
Table 112. Zydus Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Zydus Enzalutamide Drugs Product Portfolios and Specifications
Table 114. Zydus Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Zydus Main Business
Table 116. Zydus Latest Developments
Table 117. Abbott Laboratories Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Abbott Laboratories Enzalutamide Drugs Product Portfolios and Specifications
Table 119. Abbott Laboratories Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Abbott Laboratories Main Business
Table 121. Abbott Laboratories Latest Developments
Table 122. BDR Pharma Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. BDR Pharma Enzalutamide Drugs Product Portfolios and Specifications
Table 124. BDR Pharma Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. BDR Pharma Main Business
Table 126. BDR Pharma Latest Developments
Table 127. Qilu Pharmaceutical Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Qilu Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
Table 129. Qilu Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Qilu Pharmaceutical Main Business
Table 131. Qilu Pharmaceutical Latest Developments
Table 132. Kelun Pharmaceutical Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Kelun Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
Table 134. Kelun Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Kelun Pharmaceutical Main Business
Table 136. Kelun Pharmaceutical Latest Developments
Table 137. Yichang Humanwell Pharmaceutical Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Yichang Humanwell Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
Table 139. Yichang Humanwell Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Yichang Humanwell Pharmaceutical Main Business
Table 141. Yichang Humanwell Pharmaceutical Latest Developments
Table 142. Jiangsu Hansoh Pharmaceutical Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
Table 144. Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Jiangsu Hansoh Pharmaceutical Main Business
Table 146. Jiangsu Hansoh Pharmaceutical Latest Developments
Table 147. PuraCap Pharmaceuticals Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. PuraCap Pharmaceuticals Enzalutamide Drugs Product Portfolios and Specifications
Table 149. PuraCap Pharmaceuticals Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. PuraCap Pharmaceuticals Main Business
Table 151. PuraCap Pharmaceuticals Latest Developments
Table 152. Shenyang Hongqi Pharmaceutical Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
Table 154. Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Shenyang Hongqi Pharmaceutical Main Business
Table 156. Shenyang Hongqi Pharmaceutical Latest Developments
Table 1. Enzalutamide Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Enzalutamide Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Capsules
Table 5. Global Enzalutamide Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Enzalutamide Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Enzalutamide Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Enzalutamide Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Enzalutamide Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Enzalutamide Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Enzalutamide Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Enzalutamide Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Enzalutamide Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Enzalutamide Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Enzalutamide Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Enzalutamide Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Enzalutamide Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Enzalutamide Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Enzalutamide Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Enzalutamide Drugs Producing Area Distribution and Sales Area
Table 21. Players Enzalutamide Drugs Products Offered
Table 22. Enzalutamide Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Enzalutamide Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Enzalutamide Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Enzalutamide Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Enzalutamide Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Enzalutamide Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Enzalutamide Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Enzalutamide Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Enzalutamide Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Enzalutamide Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Enzalutamide Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Enzalutamide Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Enzalutamide Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Enzalutamide Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Enzalutamide Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Enzalutamide Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Enzalutamide Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Enzalutamide Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Enzalutamide Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Enzalutamide Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Enzalutamide Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Enzalutamide Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Enzalutamide Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Enzalutamide Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Enzalutamide Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Enzalutamide Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Enzalutamide Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Enzalutamide Drugs
Table 52. Key Market Challenges & Risks of Enzalutamide Drugs
Table 53. Key Industry Trends of Enzalutamide Drugs
Table 54. Enzalutamide Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Enzalutamide Drugs Distributors List
Table 57. Enzalutamide Drugs Customer List
Table 58. Global Enzalutamide Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Enzalutamide Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Enzalutamide Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Enzalutamide Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Enzalutamide Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Enzalutamide Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Enzalutamide Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Enzalutamide Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Enzalutamide Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Enzalutamide Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Enzalutamide Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Enzalutamide Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Enzalutamide Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Enzalutamide Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Astellas Pharma Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Astellas Pharma Enzalutamide Drugs Product Portfolios and Specifications
Table 74. Astellas Pharma Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Astellas Pharma Main Business
Table 76. Astellas Pharma Latest Developments
Table 77. Pfizer Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer Enzalutamide Drugs Product Portfolios and Specifications
Table 79. Pfizer Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. Intas Pharmaceuticals Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Intas Pharmaceuticals Enzalutamide Drugs Product Portfolios and Specifications
Table 84. Intas Pharmaceuticals Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Intas Pharmaceuticals Main Business
Table 86. Intas Pharmaceuticals Latest Developments
Table 87. Beacon pharma Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Beacon pharma Enzalutamide Drugs Product Portfolios and Specifications
Table 89. Beacon pharma Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Beacon pharma Main Business
Table 91. Beacon pharma Latest Developments
Table 92. Aprazer Healthcare Pharma Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Aprazer Healthcare Pharma Enzalutamide Drugs Product Portfolios and Specifications
Table 94. Aprazer Healthcare Pharma Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Aprazer Healthcare Pharma Main Business
Table 96. Aprazer Healthcare Pharma Latest Developments
Table 97. Arechar Healthcare Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Arechar Healthcare Enzalutamide Drugs Product Portfolios and Specifications
Table 99. Arechar Healthcare Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Arechar Healthcare Main Business
Table 101. Arechar Healthcare Latest Developments
Table 102. Glenmark Pharma Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Glenmark Pharma Enzalutamide Drugs Product Portfolios and Specifications
Table 104. Glenmark Pharma Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Glenmark Pharma Main Business
Table 106. Glenmark Pharma Latest Developments
Table 107. Sun Pharma Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Sun Pharma Enzalutamide Drugs Product Portfolios and Specifications
Table 109. Sun Pharma Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Sun Pharma Main Business
Table 111. Sun Pharma Latest Developments
Table 112. Zydus Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Zydus Enzalutamide Drugs Product Portfolios and Specifications
Table 114. Zydus Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Zydus Main Business
Table 116. Zydus Latest Developments
Table 117. Abbott Laboratories Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Abbott Laboratories Enzalutamide Drugs Product Portfolios and Specifications
Table 119. Abbott Laboratories Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Abbott Laboratories Main Business
Table 121. Abbott Laboratories Latest Developments
Table 122. BDR Pharma Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. BDR Pharma Enzalutamide Drugs Product Portfolios and Specifications
Table 124. BDR Pharma Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. BDR Pharma Main Business
Table 126. BDR Pharma Latest Developments
Table 127. Qilu Pharmaceutical Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Qilu Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
Table 129. Qilu Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Qilu Pharmaceutical Main Business
Table 131. Qilu Pharmaceutical Latest Developments
Table 132. Kelun Pharmaceutical Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Kelun Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
Table 134. Kelun Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Kelun Pharmaceutical Main Business
Table 136. Kelun Pharmaceutical Latest Developments
Table 137. Yichang Humanwell Pharmaceutical Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Yichang Humanwell Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
Table 139. Yichang Humanwell Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Yichang Humanwell Pharmaceutical Main Business
Table 141. Yichang Humanwell Pharmaceutical Latest Developments
Table 142. Jiangsu Hansoh Pharmaceutical Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
Table 144. Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Jiangsu Hansoh Pharmaceutical Main Business
Table 146. Jiangsu Hansoh Pharmaceutical Latest Developments
Table 147. PuraCap Pharmaceuticals Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. PuraCap Pharmaceuticals Enzalutamide Drugs Product Portfolios and Specifications
Table 149. PuraCap Pharmaceuticals Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. PuraCap Pharmaceuticals Main Business
Table 151. PuraCap Pharmaceuticals Latest Developments
Table 152. Shenyang Hongqi Pharmaceutical Basic Information, Enzalutamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Product Portfolios and Specifications
Table 154. Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Shenyang Hongqi Pharmaceutical Main Business
Table 156. Shenyang Hongqi Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Enzalutamide Drugs
Figure 2. Enzalutamide Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Enzalutamide Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Enzalutamide Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Enzalutamide Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Enzalutamide Drugs Sales Market Share by Country/Region (2025)
Figure 10. Enzalutamide Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture ofTablets
Figure 12. Product Picture of Capsules
Figure 13. Global Enzalutamide Drugs Sales Market Share by Type in 2026
Figure 14. Global Enzalutamide Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Enzalutamide Drugs Consumed in Hospital and Clinic
Figure 16. Global Enzalutamide Drugs Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 17. Enzalutamide Drugs Consumed in Retail Pharmacies
Figure 18. Global Enzalutamide Drugs Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 19. Enzalutamide Drugs Consumed in Other
Figure 20. Global Enzalutamide Drugs Market: Other (2021-2026) & (K Units)
Figure 21. Global Enzalutamide Drugs Sale Market Share by Application (2025)
Figure 22. Global Enzalutamide Drugs Revenue Market Share by Application in 2026
Figure 23. Enzalutamide Drugs Sales by Company in 2026 (K Units)
Figure 24. Global Enzalutamide Drugs Sales Market Share by Company in 2026
Figure 25. Enzalutamide Drugs Revenue by Company in 2026 ($ millions)
Figure 26. Global Enzalutamide Drugs Revenue Market Share by Company in 2026
Figure 27. Global Enzalutamide Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Enzalutamide Drugs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Enzalutamide Drugs Sales 2021-2026 (K Units)
Figure 30. Americas Enzalutamide Drugs Revenue 2021-2026 ($ millions)
Figure 31. APAC Enzalutamide Drugs Sales 2021-2026 (K Units)
Figure 32. APAC Enzalutamide Drugs Revenue 2021-2026 ($ millions)
Figure 33. Europe Enzalutamide Drugs Sales 2021-2026 (K Units)
Figure 34. Europe Enzalutamide Drugs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Enzalutamide Drugs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Enzalutamide Drugs Revenue 2021-2026 ($ millions)
Figure 37. Americas Enzalutamide Drugs Sales Market Share by Country in 2026
Figure 38. Americas Enzalutamide Drugs Revenue Market Share by Country (2021-2026)
Figure 39. Americas Enzalutamide Drugs Sales Market Share by Type (2021-2026)
Figure 40. Americas Enzalutamide Drugs Sales Market Share by Application (2021-2026)
Figure 41. United States Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Enzalutamide Drugs Sales Market Share by Region in 2026
Figure 46. APAC Enzalutamide Drugs Revenue Market Share by Region (2021-2026)
Figure 47. APAC Enzalutamide Drugs Sales Market Share by Type (2021-2026)
Figure 48. APAC Enzalutamide Drugs Sales Market Share by Application (2021-2026)
Figure 49. China Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. India Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Enzalutamide Drugs Sales Market Share by Country in 2026
Figure 57. Europe Enzalutamide Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Europe Enzalutamide Drugs Sales Market Share by Type (2021-2026)
Figure 59. Europe Enzalutamide Drugs Sales Market Share by Application (2021-2026)
Figure 60. Germany Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. France Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Enzalutamide Drugs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Enzalutamide Drugs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Enzalutamide Drugs Sales Market Share by Application (2021-2026)
Figure 68. Egypt Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Enzalutamide Drugs in 2026
Figure 74. Manufacturing Process Analysis of Enzalutamide Drugs
Figure 75. Industry Chain Structure of Enzalutamide Drugs
Figure 76. Channels of Distribution
Figure 77. Global Enzalutamide Drugs Sales Market Forecast by Region (2027-2032)
Figure 78. Global Enzalutamide Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Enzalutamide Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Enzalutamide Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Enzalutamide Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Enzalutamide Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Enzalutamide Drugs
Figure 2. Enzalutamide Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Enzalutamide Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Enzalutamide Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Enzalutamide Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Enzalutamide Drugs Sales Market Share by Country/Region (2025)
Figure 10. Enzalutamide Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture ofTablets
Figure 12. Product Picture of Capsules
Figure 13. Global Enzalutamide Drugs Sales Market Share by Type in 2026
Figure 14. Global Enzalutamide Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Enzalutamide Drugs Consumed in Hospital and Clinic
Figure 16. Global Enzalutamide Drugs Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 17. Enzalutamide Drugs Consumed in Retail Pharmacies
Figure 18. Global Enzalutamide Drugs Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 19. Enzalutamide Drugs Consumed in Other
Figure 20. Global Enzalutamide Drugs Market: Other (2021-2026) & (K Units)
Figure 21. Global Enzalutamide Drugs Sale Market Share by Application (2025)
Figure 22. Global Enzalutamide Drugs Revenue Market Share by Application in 2026
Figure 23. Enzalutamide Drugs Sales by Company in 2026 (K Units)
Figure 24. Global Enzalutamide Drugs Sales Market Share by Company in 2026
Figure 25. Enzalutamide Drugs Revenue by Company in 2026 ($ millions)
Figure 26. Global Enzalutamide Drugs Revenue Market Share by Company in 2026
Figure 27. Global Enzalutamide Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Enzalutamide Drugs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Enzalutamide Drugs Sales 2021-2026 (K Units)
Figure 30. Americas Enzalutamide Drugs Revenue 2021-2026 ($ millions)
Figure 31. APAC Enzalutamide Drugs Sales 2021-2026 (K Units)
Figure 32. APAC Enzalutamide Drugs Revenue 2021-2026 ($ millions)
Figure 33. Europe Enzalutamide Drugs Sales 2021-2026 (K Units)
Figure 34. Europe Enzalutamide Drugs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Enzalutamide Drugs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Enzalutamide Drugs Revenue 2021-2026 ($ millions)
Figure 37. Americas Enzalutamide Drugs Sales Market Share by Country in 2026
Figure 38. Americas Enzalutamide Drugs Revenue Market Share by Country (2021-2026)
Figure 39. Americas Enzalutamide Drugs Sales Market Share by Type (2021-2026)
Figure 40. Americas Enzalutamide Drugs Sales Market Share by Application (2021-2026)
Figure 41. United States Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Enzalutamide Drugs Sales Market Share by Region in 2026
Figure 46. APAC Enzalutamide Drugs Revenue Market Share by Region (2021-2026)
Figure 47. APAC Enzalutamide Drugs Sales Market Share by Type (2021-2026)
Figure 48. APAC Enzalutamide Drugs Sales Market Share by Application (2021-2026)
Figure 49. China Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. India Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Enzalutamide Drugs Sales Market Share by Country in 2026
Figure 57. Europe Enzalutamide Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Europe Enzalutamide Drugs Sales Market Share by Type (2021-2026)
Figure 59. Europe Enzalutamide Drugs Sales Market Share by Application (2021-2026)
Figure 60. Germany Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. France Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Enzalutamide Drugs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Enzalutamide Drugs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Enzalutamide Drugs Sales Market Share by Application (2021-2026)
Figure 68. Egypt Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Enzalutamide Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Enzalutamide Drugs in 2026
Figure 74. Manufacturing Process Analysis of Enzalutamide Drugs
Figure 75. Industry Chain Structure of Enzalutamide Drugs
Figure 76. Channels of Distribution
Figure 77. Global Enzalutamide Drugs Sales Market Forecast by Region (2027-2032)
Figure 78. Global Enzalutamide Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Enzalutamide Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Enzalutamide Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Enzalutamide Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Enzalutamide Drugs Revenue Market Share Forecast by Application (2027-2032)
